Specialty Drug

Glatiramer Acetate

Copaxone (glatiramer acetate) is an immunomodulator used to reduce the frequency of relapses in patients with multiple sclerosis (MS). It is not an interferon, but may be grouped with interferon betas Avonex and Betaseron; together the three first-line treatments are sometimes known as the "ABC" drugs for MS. The exact mechanism of action of Copaxone in patients with MS is unknown. A generic form of glatiramer acetate is also available under the name Glatopa, but only for the once-daily injection. The lowest GoodRx price for the most common version of glatopa is around $1,953.29, 30% off the average retail price of $2,800.71. Compare interferon betas.

Copaxone Latest News

Get the latest updates on this drug from the GoodRx medical team

2015 In Review: The Good(Rx) and Bad

Elizabeth Davis - December 29, 2015

2015 was another tough year for American’s health care budgets. Insurance premiums increased, coverage was dropped for a number of important drugs, and overall we’re spending more for our health care.

Don’t break out the antidepressants yet—it’s not all bad news. A number of important drugs went generic, which will generally mean huge savings and lower costs. Plus, a large number of drugs actually decreased in price. See More

New Copaxone Generic Launched! Look for Glatopa in Pharmacies Soon

Roni Shye - June 26, 2015

Glatopa, the new generic alternative to multiple sclerosis (MS) treatment Copaxone, was approved earlier this year, and its launch has been anxiously awaited. Now, the time has come, and Glatopa will be available in pharmacies soon!

Manufacturer Sandoz announced last Thursday, June 18, that Glatopa has began shipping following its recent FDA approval.

Is Glatopa an FDA approved generic?

Yes. Glatopa has been approved by the FDA as a substitutable generic for the brand-name drug CopaxoneSee More

New Copaxone Generic Now Approved: Glatopa May Reduce Treatment Costs

Roni Shye - May 01, 2015

Multiple sclerosis (MS) is a debilitating autoimmune disease that currently does not have a cure. It affects around 400,000 people in the United States alone, with symptoms presenting most often between 20 and 40 years of age.

Copaxone (glatiramer acetate), one of the most popular treatments for multiple sclerosis, has recently received generic FDA approval under the name Glatopa.

The FDA approval of Glatopa is a big deal for patients being treated for MS, especially since medication costs for this condition are nearing $60,000 a year. See More

Copaxone Three Times a Week: Better, or Just More Expensive?

Dr. Sharon Orrange - June 04, 2014

Yes, three times a week is more convenient than once a day . . . but it will cost you more in the end and here’s why. Copaxone 20 mg daily injection has been one of the major medications used in the treatment of multiple sclerosis (MS). What you should know is that the patent for Copaxone (glatiramer acetate) is set to expire this month (May 2014) but Teva is fighting that. You see, two companies would like to make a generic Copaxone (glatiramer) which will be cheaper for you. See More

New Three-Times-Weekly Dose of Copaxone Now Available

Elizabeth Davis - January 30, 2014

Good news for multiple sclerosis (MS) patients taking Copaxone (glatiramer acetate)—the FDA has approved a new three-times-weekly dose. The new dose will still be a subcutaneous injection, but will have a higher concentration at 40 mg/ml. Copaxone is currently available as 20 mg/ml injection, taken once daily. The new strength is approved in addition to the lower daily dose, and will not replace it.

The approval was based on a study that showed the 40 mg/ml dose given three times weekly reduced relapse rates by as much as 1/3 at twelve months, compared with a placebo. See More

Aubagio: The New Pill Approved for Multiple Sclerosis (MS)

Dr. Sharon Orrange - October 10, 2012

Many have been waiting for a pill for MS, and here it is. Injectables (Avonex, Betaseron, Copaxone and Rebif) are currently the mainstay of treatment for MS, so realize that most MS patients are currently injecting themselves once daily or once a week. Now, there may be a pill option. This month the Food and Drug Administration (FDA) announced the approval of Aubagio (teriflunomide), a once-daily tablet for the treatment of multiple sclerosis. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.
Safe Pharmacy